1-20 of 8900
Sort by
Journal Article
ACCEPTED MANUSCRIPT
Stefano Comai and others
International Journal of Neuropsychopharmacology, pyaf025, https://doi.org/10.1093/ijnp/pyaf025
Published: 21 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Paul Faulkner and others
International Journal of Neuropsychopharmacology, pyaf026, https://doi.org/10.1093/ijnp/pyaf026
Published: 21 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Ju-Wei Hsu and others
International Journal of Neuropsychopharmacology, pyaf024, https://doi.org/10.1093/ijnp/pyaf024
Published: 12 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Jacob S Aday and others
International Journal of Neuropsychopharmacology, pyaf023, https://doi.org/10.1093/ijnp/pyaf023
Published: 04 April 2025
Journal Article
ACCEPTED MANUSCRIPT
D Behzad and others
International Journal of Neuropsychopharmacology, pyaf021, https://doi.org/10.1093/ijnp/pyaf021
Published: 02 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Christoph U Correll and others
International Journal of Neuropsychopharmacology, pyaf018, https://doi.org/10.1093/ijnp/pyaf018
Published: 01 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Luo-Xuan Wang and others
International Journal of Neuropsychopharmacology, pyaf019, https://doi.org/10.1093/ijnp/pyaf019
Published: 31 March 2025
Journal Article
ACCEPTED MANUSCRIPT
Hernan F Guillen-Burgos and others
International Journal of Neuropsychopharmacology, pyaf020, https://doi.org/10.1093/ijnp/pyaf020
Published: 29 March 2025
Journal Article
ACCEPTED MANUSCRIPT
Michal Lazar and others
International Journal of Neuropsychopharmacology, pyaf022, https://doi.org/10.1093/ijnp/pyaf022
Published: 29 March 2025
Image
Published: 28 March 2025
Figure 2. The rates of antipsychotic monotherapy and complete antipsychotic monotherapy in the clozapine-available institution (CAI) group and the clozapine-unavailable institution (CUI) group when patients who were prescribed clozapine were excluded. (A) The rate of antipsychotic monotherapy in the CAI group
Image
Published: 28 March 2025
Figure 1. The rates of antipsychotic monotherapy and complete antipsychotic monotherapy between the clozapine-available institution (CAI) group and the clozapine-unavailable institution (CUI) group. (A) The rate of antipsychotic monotherapy in the CAI group was significantly higher than that in the CUI group.
Journal Article
Shinichiro Ochi and others
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf011, https://doi.org/10.1093/ijnp/pyaf011
Published: 28 March 2025
Image
Published: 28 March 2025
Figure 3. The rates of antipsychotic monotherapy and complete antipsychotic monotherapy between the clozapine-available institution (CAI) group and the clozapine-unavailable institution (CUI) group, regardless of whether treatment-resistant schizophrenia subgroups were described. (A) The rate of antipsychotic
Journal Article
ACCEPTED MANUSCRIPT
Martha López-Canul and others
International Journal of Neuropsychopharmacology, pyaf017, https://doi.org/10.1093/ijnp/pyaf017
Published: 23 March 2025
Journal Article
Sou Sugiki and others
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf016, https://doi.org/10.1093/ijnp/pyaf016
Published: 15 March 2025
Image
Published: 15 March 2025
Figure 1. Clinical trial flow. *In the comparison of the correlation between venous plasma and fingertip whole blood for D-Pro (%) or D-Ala (%), outliers are defined as those with standardized residuals exceeding 2.0.
Image
Published: 15 March 2025
Figure 2. (A) Correlation comparison of amino acid concentrations in venous and fingertip blood. Red dots indicate data points with outliers. (B) Correlation comparison of amino acid concentrations and D-amino acid (%) in venous and fingertip blood, excluding outliers.
Image
Published: 15 March 2025
Figure 3. Scatterplots showing group differences in the concentration of D-Pro (%) and D-Ala (%) in whole fingertip blood. Black horizontal lines denote the median value. Differences in each concentration between the cognitively normal (CN) group and the suspected MCI group (MCI) by sex were explored using th
Image
Published: 15 March 2025
Figure 4. (A) The ROC curve when a kernel SVM model was constructed using relatively easily obtainable participant background information (sex, age, BMI, education years, number of people living together, and family composition), and LOOCV was performed. (B) The ROC curve when a kernel SVM model was construct
Image
Published: 15 March 2025
Figure 5. (A) The ROC curve (kernel SVM, LOOCV) when the criterion for sus-MCI was set to MMSE ≤ 26. (B) The ROC curve (kernel SVM, LOOCV) when the criterion for sus-MCI was set to MMSE ≤ 27. (C) The ROC curve (kernel SVM, LOOCV) when the borderline MMSE scores of 26 and 27 were excluded. LOOCV, leave-one-out